Lv53
1180 积分 2022-07-06 加入
Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells
9天前
已完结
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
1个月前
已完结
A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances
2个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
5个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
7个月前
已完结
Tislelizumab augment the efficacy of CD19/22 dual‐targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B‐cell non‐Hodgkin lymphoma
8个月前
已完结
Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity
8个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
8个月前
已完结
Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site
9个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
9个月前
已完结
皖公网安备34019202002308
